|
gptkbp:instanceOf
|
gptkb:chemical_compound
hydrazine derivative
|
|
gptkbp:affects
|
gptkb:monoamine_oxidase
|
|
gptkbp:ATCCode
|
gptkb:N06AF03
|
|
gptkbp:boilingPoint
|
-
|
|
gptkbp:CASNumber
|
64-17-5
|
|
gptkbp:chemicalFormula
|
C8H12N2
|
|
gptkbp:contraindication
|
gptkb:tricyclic_antidepressants
gptkb:SSRIs
gptkb:sympathomimetics
|
|
gptkbp:discoveredIn
|
1950s
|
|
gptkbp:drugClass
|
monoamine oxidase inhibitor
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:halfLife
|
11.6 hours
|
|
gptkbp:hasInChIKey
|
QKJXJQGZQGJVFO-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
NNCc1ccccc1
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
phenylethylhydrazine
|
|
gptkbp:isHydrazineDerivativeOf
|
phenylethylamine
|
|
gptkbp:IUPACName
|
gptkb:2-phenylethylhydrazine
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
-
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
136.19 g/mol
|
|
gptkbp:PubChem_CID
|
4767
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
weight gain
insomnia
hypertensive crisis (with tyramine)
|
|
gptkbp:synonym
|
gptkb:2-phenylethylhydrazine
gptkb:Nardil
gptkb:phenelzine
beta-phenylethylhydrazine
|
|
gptkbp:usedAs
|
antidepressant
|
|
gptkbp:usedFor
|
gptkb:panic_disorder
gptkb:social_anxiety_disorder
gptkb:major_depressive_disorder
atypical depression
|
|
gptkbp:bfsParent
|
gptkb:Phenelzine
|
|
gptkbp:bfsLayer
|
7
|